Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Endothelial dysfunction predicts regression of hypertensive cardiac mass.
Perticone F, Maio R, Perticone M, Miceli S, Sciacqua A, Tassone EJ, Shehaj E, Tripepi G, Sesti G. Perticone F, et al. Among authors: shehaj e. Int J Cardiol. 2013 Aug 20;167(4):1188-92. doi: 10.1016/j.ijcard.2012.03.138. Epub 2012 Apr 11. Int J Cardiol. 2013. PMID: 22498421
Effect of normalization of fasting glucose by intensified insulin therapy and influence of eNOS polymorphisms on the incidence of restenosis after peripheral angioplasty in patients with type 2 diabetes: a randomized, open-label clinical trial.
Piatti PM, Marone E, Mantero M, Setola E, Galluccio E, Lucotti P, Shehaj E, Villa V, Perticone F, Venturini M, Palini A, Airoldi F, Faglia E, Del Maschio A, Colombo A, Chiesa R, Bosi E, Monti LD. Piatti PM, et al. Among authors: shehaj e. Acta Diabetol. 2013 Jun;50(3):373-82. doi: 10.1007/s00592-012-0426-x. Epub 2012 Aug 21. Acta Diabetol. 2013. PMID: 22907764 Clinical Trial.
[Renal effects of sodium-glucose cotransporter 2 inhibitors in patients with cardiovascular disease with and without chronic kidney disease].
Benvenuto M, Panzarella G, Shehaj E, Valenti C, Caldarola P, Colivicchi F, Gabrielli D, Iacoviello M; a nome dell’Area CArdio REno MEtabolica (CARE ME) dell’Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO). Benvenuto M, et al. Among authors: shehaj e. G Ital Cardiol (Rome). 2023 Mar;24(3):188-195. doi: 10.1714/3980.39621. G Ital Cardiol (Rome). 2023. PMID: 36853155 Review. Italian.
Liraglutide and Renal Outcomes in Type 2 Diabetes.
Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, Tornøe K, Zinman B, Buse JB; LEADER Steering Committee and Investigators. Mann JFE, et al. N Engl J Med. 2017 Aug 31;377(9):839-848. doi: 10.1056/NEJMoa1616011. N Engl J Med. 2017. PMID: 28854085 Free article. Clinical Trial.
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee; LEADER Trial Investigators. Marso SP, et al. N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13. N Engl J Med. 2016. PMID: 27295427 Free PMC article. Clinical Trial.
Basal insulin and cardiovascular and other outcomes in dysglycemia.
ORIGIN Trial Investigators; Gerstein HC, Bosch J, Dagenais GR, Díaz R, Jung H, Maggioni AP, Pogue J, Probstfield J, Ramachandran A, Riddle MC, Rydén LE, Yusuf S. ORIGIN Trial Investigators, et al. N Engl J Med. 2012 Jul 26;367(4):319-28. doi: 10.1056/NEJMoa1203858. Epub 2012 Jun 11. N Engl J Med. 2012. PMID: 22686416 Free article. Clinical Trial.
11 results